(Q36243757)

13 August 2017

1 reference

title

Familial non-BRCA1/BRCA2-associated breast cancer (English)

1 reference

13 August 2017

Diana M Eccles

1

0 references

author name string

Gabriella Pichert

series ordinal

2

1 reference

13 August 2017

1 September 2005

1 reference

Lancet Oncology Commission

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

705-711

1 reference

13 August 2017

9

1 reference

Polygenic susceptibility to breast cancer and implications for prevention

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Relative frequency and morphology of cancers in STK11 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

ATM and genome maintenance: defining its role in breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

The genetic epidemiology of breast cancer genes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Polymorphisms associated with circulating sex hormone levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Association studies for finding cancer-susceptibility genetic variants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

The pathology of familial breast cancer: Morphological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Hallmarks of 'BRCAness' in sporadic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Molecular classification of familial non-BRCA1/BRCA2 breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Gene-expression profiling in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Development of molecular targeted anticancer agents: successes, failures and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

State of the science: molecular classifications of breast cancer for clinical diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Breast cancer risk perception: what do we know and understand?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Prevention and genetic testing for breast cancer: variations in medical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Uptake of screening and prevention in women at very high risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Evidence based case report: Advice about mammography for a young woman with a family history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Prophylactic mastectomy for the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Conservative management of breast cancer in BRCA1/2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970318-1

7 January 2021

10.1016/S1470-2045(05)70318-1

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16129371